In the first study of its kind, researchers have demonstrated novel and previously unknown mechanisms of action by which BCM-95 Curcumin and BosPure Boswellia work synergistically to prevent colorectal cancer and demonstrate anti-tumor activity in both in vitro and in vivo.

“We have known for awhile that curcumin and boswellia both have potent anti-cancer properties,: said Ajay Goel, PhD, one of the study’s authors. “In this study, we investigated how they work in conjunction to reduce proliferation and increase cell cycle arrest and apoptosis (various mechanisms by which cancer cells are killed). We found that the two together activate a broader array of gene regulators called microRNAs, with a wider spectrum of impact compared to either compound individually.”